As­traZeneca adds chron­ic kid­ney dis­ease TV ad to Farx­i­ga port­fo­lio

As­traZeneca is adding a third ar­row to its Farx­i­ga TV ad quiver. De­but­ing to­day, the new com­mer­cial takes aim at chron­ic kid­ney dis­ease, fol­low­ing AZ’s long-time TV ad­ver­tis­ing of the SGLT2 in­hibitor for Type 2 di­a­betes and more re­cent­ly heart fail­ure.

Chron­ic kid­ney dis­ease (CKD) is on the rise, af­fect­ing an es­ti­mat­ed one in sev­en or about 37 mil­lion US adults. How­ev­er, nine out of 10 peo­ple with CKD have not been di­ag­nosed, ac­cord­ing to da­ta from the CDC.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER